South Florida
Integrated Kidney Partners II LLC
Primary Contact
Ryan Pardo
Ryan.Pardo@usrenalcare.com
KCE Participants
Dialysis Facilities
5072020, LLC | 70820 VENTURES, LLC |
USRC UPTOWN NAPLES LLC | 71120 VENTURES, LLC |
71020 VENTURES, LLC | 70920 VENTURES, LLC |
70620 PARTNERS, LLC | 70720 PARTNERS, LLC |
USRC MUSTANG DIALYSIS, LLC | NEW SMYRNA BEACH ARTIFICIAL KIDNEY, LC |
Practices
ASSOCIATES IN NEPHROLOGY BUTCHER & DEVACAANTHAN MD PA
AASTHA PARSA | PEGGY DEPALMA |
NICOLE WILCOX | MARY MOURACADE |
KATIE ANDERSON | TAMIM GHITH |
BASUDEV PUDASAINI | NEETU MALHOTRA |
BISHAL RAWAL | ROBERT LIBBEY |
EVAN GROSS | ROBERT PAYNE |
JOEL VANSICKLER | SOURAB DHUNGEL |
JOHN CONREY | SYEDA KHAN |
MAGDALA GUERRIER |
MOGILISHETTY PLLC
ANDREW NOWAKOWSKI | BEENU SINGH |
GAUTHAM MOGILISHETTY | IBRAHIM KHAMBATI |
MELONEY OLIVEIRA |
Independent Practitioner
CHRISTOPHER MAI |
Preferred Providers
Practice | |
PERSONAL RECOVERY NETWORK LLC | |
Joint Ventures
There are no joint ventures between or among the KCE and any of its KCE Participant and Preferred Providers.
Administrative Lead
Name | Employer |
Alan St. Pierre | U.S. Renal Care |
Clinical Lead
Name | Employer |
Bishal Rawal | Associates in Nephrology |
KCE Governing Body Members
Name | Employer |
Alan St. Pierre | U.S. Renal Care |
Bishal Rawal | Associates in Nephrology |
Basudev Pudasaini | Associates in Nephrology |
Natasha Dave | Associates in Nephrology` |
Carol Ecklund | U.S. Renal Care |
Gautham Mogilishetty | Mogilishetty PLLC |
Lori Hartwell | Consumer Advocate |
Stephen Busenlehner | U.S. Renal Care |
Shared Savings and Shared Losses Information
a. Gross Savings/Losses BEFORE CMS withholds:
PY2022: $1,598,972
b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation;
PY2022: ($71,294)
c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2022: N/A
d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2022: N/A
d. The KCE’s performance on the quality measures used to calculate the KCE’s TQS, as described in the Quality Overview Document and Measure Specifications Document.
PY2022 TQS: 25%*
*Devastation from Hurricane Ian prevented performance on Quality measures. CMS did not provide relief on Quality performance via Extreme and Unexpected Circumstances.
e. Total Ancillary Income*
PY2022: $706,889
*Includes (1) 100% of Installment 1 2022 Kidney Transplant Bonus (KTB) (2) 100% of post-sequestration home dialysis bonus and (3) 100% of post-sequestration capitation payments deposited quarterly